PROFILE THERAPEUTICS
Similar Organizations
ImCure Therapeutics
ImCure Therapeutics
Transkaryotic Therapies, Inc
Transkaryotic Therapies
Traxion Therapeutics Inc
Traxion Therapeutics Inc
More informations about "Profile Therapeutics"
Profile Therapeutics Company Profile 2024: Valuation, Investors ...
When was Profile Therapeutics founded? Profile Therapeutics was founded in 1977. Where is Profile Therapeutics headquartered? Profile Therapeutics is headquartered in Bognor Regis, …See details»
Profile Therapeutics - Products, Competitors, Financials, Employees ...
About Profile Therapeutics Developer, manufacturer and distributor of inhaled drug delivery systems. The company's products fall into two main categories: Conventional nebulizer …See details»
Profile Therapeutics - Drug pipelines, Patents, Clinical trials - Synapse
Explore Profile Therapeutics with its drug pipeline, therapeutic area, technology platform, 1 news.See details»
Profile Therapeutics plc - VentureRadar
Profile Therapeutics plc VentureRadar profile. Find out more about Profile Therapeutics plc including the VentureRadar Innovation and Growth scores, Similar Companies and more. ...See details»
Profile Therapeutics - Crunchbase Company Profile & Funding
Alternatives and possible competitors to Profile Therapeutics may include ImCure Therapeutics, Traxion Therapeutics Inc, and Transkaryotic Therapies, Inc. Unlock even more features with …See details»
ATC and Profile to develop emphysema drug
Aug 11, 2002 Under the terms of this agreement, ATC will develop its alpha-1 PI product as a therapy to be delivered directly to the lung, via an aerosolized solution, using a customized …See details»
Altamira Therapeutics Ltd. (CYTOF) Company Profile & Overview
3 days ago Altamira Therapeutics Ltd. operates as a preclinical-stage biopharmaceutical company in Switzerland and Australia. The company develops and supplies …See details»
Keltic Pharma Therapeutics - Crunchbase Company Profile
Keltic Pharma Therapeutics enhances drug discovery through innovative scientific research, resulting in a healthier future. Glasgow , Glasgow City , United Kingdom 11-50See details»
APLT INVESTOR NOTICE: Robbins Geller Rudman & Dowd LLP …
1 day ago Contacts. Robbins Geller Rudman & Dowd LLP J.C. Sanchez, Jennifer N. Caringal 655 W. Broadway, Suite 1900, San Diego, CA 92101 800-449-4900 [email protected]See details»
1:24-cv-01363 | Heron Therapeutics, Inc. v. Azurity Pharmaceuticals ...
Parties, patents and docket of Heron Therapeutics Inc. v. Azurity Pharmaceuticals Inc. and 2 other defendants (1:24-cv-01363) from District of Delaware filed on 12/12/2024See details»
Unique cancer vaccines target immunotherapy - Nature
Swiss-based AMAL Therapeutics is developing KISIMA, a unique protein-based immunization platform capable of producing single therapeutic vaccines for immunotherapy and beyond.See details»
Akava Therapeutics - Funding, Financials, Valuation & Investors
Akava Therapeutics is a small molecule therapeutics that inhibits protein aggregation, enzymes, and cancer for neurodegenerative diseases. ... How much funding has this organization raised …See details»
Horizon Therapeutics Company Profile - Office Locations ... - Craft
Davidson Kempner Capital Management LP : Form 8.3 - Horizon Therapeutics PLC Jan 23, 2023 Corporate Reputation of Pharma Companies in United States, 2021-2022: The Views of 240 …See details»
Altamira Therapeutics Ltd. | Company Profile - OTC Markets
2 days ago Altamira Therapeutics (CYTO) is developing and supplying peptide-based nanoparticle technologies for efficient RNA delivery to extrahepatic tissues (OligoPhore / …See details»
ME Therapeutics Holdings Inc. (CSE: METX) Company Profile
2 days ago ME Therapeutics Holdings Inc., a preclinical stage biotechnology company, engages in the development of cancer fighting drugs in the field of immuno‐oncology. Its lead …See details»
Context Therapeutics - Crunchbase Company Profile & Funding
Context Therapeutics is a clinical-stage biopharmaceutical company dedicated to creating new medicines to treat hormone-responsive cancers. Context’s lead program is Apristor …See details»
Cara Therapeutics and Tvardi Therapeutics Announce Entry
3 days ago Upon completion of the Merger, pre-Merger Cara Therapeutics stockholders are expected to own approximately 17.0% of the combined company and pre-Merger Tvardi …See details»
Malena Therapeutics | Innovate@BU - Boston University
Team Profile Malena Therapeutics Malena Therapeutics is developing molecules to target and degrade RNA-binding proteins associated with neurodegeneration. Malena Therapeutics is …See details»
Travere Therapeutics, Inc. (NASDAQ:TVTX) Holdings ... - MarketBeat
1 day ago Travere Therapeutics Stock Down 1.3 %. Travere Therapeutics Still On The Rise After Encouraging Data ; Travere Therapeutics stock opened at $17.18 on Friday. Travere …See details»
Partner Therapeutics - Crunchbase Company Profile & Funding
Partner Therapeutics is a developer of drugs for oncology treatment. The company focuses on the development and commercialization of approved and late-stage therapies that improve …See details»